KELYB:NASDAQKelly Services, Inc. Analysis
Data as of 2026-04-12 - not real-time
$15.59
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Kelly Services (KELYB) is trading at $15.59, comfortably above its 20‑day SMA of $13.83 and its 50‑day SMA of $15.09, indicating short‑term price strength. The 14‑day RSI sits at 57.8, suggesting neutral‑to‑slightly bullish momentum. A bullish MACD crossover (line = 0.27, signal = ‑0.06) adds further technical support. Current price sits midway between the computed support of $12.10 and resistance of $18.58, leaving upside room. Volume is trending upward, yet daily volume (~4.6 K) is far below the 10‑day average of 50 K, pointing to thin liquidity. The 30‑day volatility of 74% and a computed beta of –2.47 signal a highly erratic price profile.
Fundamentally, the company posted $4.25 B of revenue but suffered an 11.9% YoY decline and a negative profit margin of –5.98%, with trailing EPS of –$7.24. Operating cash flow remains positive at $122 M and free cash flow at $170 M, partially offsetting the earnings shortfall. Balance‑sheet metrics are mixed: cash of $33 M versus debt of $159 M yields a debt‑to‑equity of 16.3, indicating leverage pressure. The stock trades at a price‑to‑book of 0.55 and a price‑to‑sales of 0.13, far below industry averages, while the DCF‑derived fair value of $63.83 suggests substantial upside. A 1.92% dividend yield is being paid despite negative earnings, raising concerns about sustainability. Recent material news about a strategic agreement with Hunt Equity Opportunities and new board appointments could provide a catalyst for operational improvement.
Fundamentally, the company posted $4.25 B of revenue but suffered an 11.9% YoY decline and a negative profit margin of –5.98%, with trailing EPS of –$7.24. Operating cash flow remains positive at $122 M and free cash flow at $170 M, partially offsetting the earnings shortfall. Balance‑sheet metrics are mixed: cash of $33 M versus debt of $159 M yields a debt‑to‑equity of 16.3, indicating leverage pressure. The stock trades at a price‑to‑book of 0.55 and a price‑to‑sales of 0.13, far below industry averages, while the DCF‑derived fair value of $63.83 suggests substantial upside. A 1.92% dividend yield is being paid despite negative earnings, raising concerns about sustainability. Recent material news about a strategic agreement with Hunt Equity Opportunities and new board appointments could provide a catalyst for operational improvement.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price above short‑term moving averages
- High volatility and thin trading volume
- Negative earnings but positive cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Significant valuation gap (P/B 0.55, DCF fair value $63.8)
- Leverage concerns (debt‑to‑equity 16.3)
- Strategic partnership with Hunt Equity Opportunities
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential upside to DCF fair value
- Sustainable operating cash flow despite earnings loss
- Low price‑to‑sales and price‑to‑book ratios
Key Metrics & Analysis
Financial Health
Revenue Growth-11.90%
Profit Margin-5.98%
ROE-22.98%
ROA1.40%
Debt/Equity16.29
P/B Ratio0.5
Op. Cash Flow$122.6M
Free Cash Flow$170.6M
Industry P/E30.9
Technical Analysis
TrendNeutral
RSI57.8
Support$12.10
Resistance$18.58
MA 20$13.83
MA 50$15.09
MA 200$12.65
MACDBullish
VolumeIncreasing
Fear & Greed Index87.09
Valuation
Fair Value$63.83
GradeUndervalued
TypeValue
Dividend Yield1.92%
Risk Assessment
Beta-2.47
Volatility74.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.